相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Small Molecule-facilitated Degradation of ANO1 Protein
Anke Bill et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The Ca2+-activated Cl- channel, ANO1 (TMEM16A), is a double-edged sword in cell proliferation and tumorigenesis
Zhiqiang Qu et al.
CANCER MEDICINE (2014)
Androgen Receptor Roles in the Development of Benign Prostate Hyperplasia
Kouji Izumi et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
OPINION The link between benign prostatic hyperplasia and prostate cancer
David D. Orsted et al.
NATURE REVIEWS UROLOGY (2013)
Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling
Adrian Britschgi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
MONNA, a Potent and Selective Blocker for Transmembrane Protein with Unknown Function 16/Anoctamin-1
Soo-Jin Oh et al.
MOLECULAR PHARMACOLOGY (2013)
Membrane depolarization is the trigger for PI3K/Akt activation and leads to the generation of ROS
Shampa Chatterjee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Inhibition of Ca2+-activated Cl- channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma
Wen Liu et al.
CANCER LETTERS (2012)
The effect of soy exposure in different ages on the mammary tumor development of the MMTV-ErbB-2 transgenic mice
Xiaoshan Feng et al.
CANCER RESEARCH (2012)
The Correlation Between Metabolic Syndrome and Prostatic Diseases
Cosimo De Nunzio et al.
EUROPEAN UROLOGY (2012)
The calcium-activated chloride channel anoctamin 1 acts as a heat sensor in nociceptive neurons
Hawon Cho et al.
NATURE NEUROSCIENCE (2012)
Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms
Aruna V. Sarma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Anoctamin 1 (Tmem16A) Ca2+-activated chloride channel stoichiometrically interacts with an ezrin-radixin-moesin network
Patricia Perez-Cornejo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Association of Symptomatic Benign Prostatic Hyperplasia and Prostate Cancer: Results from the Prostate Cancer Prevention Trial
Jeannette M. Schenk et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Ano1 as a regulator of proliferation
Jennifer E. Stanich et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Association of Clinical Benign Prostate Hyperplasia with Prostate Cancer Incidence and Mortality Revisited: A Nationwide Cohort Study of 3 009 258 Men
David D. Orsted et al.
EUROPEAN UROLOGY (2011)
The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation
Cosimo De Nunzio et al.
EUROPEAN UROLOGY (2011)
TMEM16A Inhibitors Reveal TMEM16A as a Minor Component of Calcium-activated Chloride Channel Conductance in Airway and Intestinal Epithelial Cells
Wan Namkung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Michelle C. Mendoza et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Inhibition of Ca2+-activated Cl- channels by gallotannins as a possible molecular basis for health benefits of red wine and green tea
Wan Namkung et al.
FASEB JOURNAL (2010)
Expression of anoctamin 1/TMEM16A by interstitial cells of Cajal is fundamental for slow wave activity in gastrointestinal muscles
Sung Jin Hwang et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
UA62784, a novel inhibitor of centromere protein E kinesin-like protein
Meredith C. Henderson et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Expression cloning of TMEM16A as a calcium-activated chloride channel subunit
Bjoern Christian Schroeder et al.
CELL (2008)
The transmembrane protein TMEM16A is required for normal development of the murine trachea
Jason R. Rock et al.
DEVELOPMENTAL BIOLOGY (2008)
TMEM16A confers receptor-activated calcium-dependent chloride conductance
Young Duk Yang et al.
NATURE (2008)
TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity
Antonella Caputo et al.
SCIENCE (2008)
Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia
Weide Zhong et al.
CLINICAL AND INVESTIGATIVE MEDICINE (2008)
Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display
A Carles et al.
ONCOGENE (2006)
Volume-sensitive chloride channels involved in apoptotic volume decrease and cell death
Y. Okada et al.
JOURNAL OF MEMBRANE BIOLOGY (2006)
Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays
E Sonneveld et al.
TOXICOLOGICAL SCIENCES (2005)
The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status
RB West et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia -: A population-based cohort study in Sweden
AP Chokkalingam et al.
CANCER (2003)
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
SY Wang et al.
CANCER CELL (2003)
Calculated fast-growing benign prostatic hyperplasia -: A risk factor for developing clinical prostate cancer
J Hammarsten et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2002)
The program of androgen-responsive genes in neoplastic prostate epithelium
PS Nelson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells
X Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation
F Claessens et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2001)
Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia
G Bartsch et al.
EUROPEAN UROLOGY (2000)
分享论文
